TY  - JOUR
AU  - de la Calle, Cristina
AU  - Lopez-Medrano, Francisco
AU  - Pablos, José Luis
AU  - Lora-Tamayo, Jaime
AU  - Maestro-de la Calle, Guillermo
AU  - Sanchez-Fernandez, Marcos
AU  - Fernandez-Ruiz, Mario
AU  - Perez-Jacoiste Asin, Maria Asunción
AU  - Caro-Teller, Jose Manuel
AU  - Garcia-Garcia, Rocio
AU  - Catalan, Mercedes
AU  - Martinez-López, Joaquín
AU  - Sevillano, Angel
AU  - Origüen, Julia
AU  - Ripoll, Mar
AU  - San Juan, Rafael
AU  - Lalueza, Antonio
AU  - de Miguel, Borja
AU  - Carretero, Octavio
AU  - Aguilar, Fernando
AU  - Gómez, Carlos
AU  - Paz-Artal, Estela
AU  - Bueno, Hector
AU  - Lumbreras, Carlos
AU  - Aguado, José María
PY  - 2021
DO  - 10.1016/j.ijid.2021.02.041
SN  - 1201-9712
UR  - http://hdl.handle.net/20.500.12105/13431
AB  - A subgroup of patients with SARS-CoV-2 infection was thought to have developed cytokine release syndrome and were treated with tocilizumab; however, a significant percentage of patients evolved. This study aimed to determine the usefulness of anakinra...
LA  - eng
PB  - Elsevier
KW  - SARS-CoV-2
KW  - Aged
KW  - Antibodies, Monoclonal, Humanized
KW  - COVID-19
KW  - Case-Control Studies
KW  - Cohort Studies
KW  - Cytokine Release Syndrome
KW  - Female
KW  - Hospital Mortality
KW  - Humans
KW  - Immunomodulation
KW  - Interleukin 1 Receptor Antagonist Protein
KW  - Male
KW  - Middle Aged
KW  - Retrospective Studies
KW  - Salvage Therapy
KW  - Spain
KW  - Treatment Failure
KW  - Treatment Outcome
TI  - Effectiveness of anakinra for tocilizumab-refractory severe COVID-19: A single-centre retrospective comparative study.
TY  - journal article
ER  -